Nilotinib Hydrochloride Monohydrate

Especificaciones

923288-90-8Número CAS

692-062-6Número CE

4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;hydrate;hydrochlorideNombre IUPAC

C28H25ClF3N7O2Fórmula química

584 g/molPeso molecular

923288-90-8; Nilotinib hydrochloride monohydrate; Nilotinib monohydrochloride monohydrate; Nilotinib hydrochloride hydrate; 5JHU0N1R6K; Nilotinib hydrochloride hydrate [JAN]; Nilotinib hydrochloride monohydrate [Orange Book]; DTXSID00238967; Nilotinib hydrochloride hydrate (JAN); NILOTINIB HYDROCHLORIDE MONOHYDRATE [MI]; Benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:1:1); NILOTINIB HYDROCHLORIDE MONOHYDRATE [EP MONOGRAPH]; NILOTINIB HYDROCHLORIDE MONOHYDRATE (EP MONOGRAPH); 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-benzamide, Monohydrochloride; 4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide monohydrochloride monohydrate; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, Monohydrochloride; 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide monohydrochloride monohydrate; Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, hydrochloride, hydrate (1:1:1); RefChem:854151; DTXCID50161458; 641571-10-0, Nilotinib; Nilotinib HCl monohydrate; Nilotinib (monohydrochloride monohydrate); 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}benzamide hydrochloride hydrate; MFCD18251359; 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide hydrochloride hydrate; AMN107 (monohydrochloride monohydrate); Nilotinib HCl hydrate; 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;hydrate;hydrochloride; Nilotinib (as hydrochloride); 923288-90-8 (HCl hydrate); UNII-5JHU0N1R6K; Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, hydrochloride, hydrate (1:1:1); Nilotinib monohydrochloride monohydrate; Tasigna (TN); AMN107 HCl hydrate; C28H25ClF3N7O2; SCHEMBL235245; orb1306342; CHEMBL1201740; SCHEMBL29392981; SCHEMBL29693815; EX-A8380A; GLXC-90221; HMS5086F16; HY-10159AR; HY-10159A; s4895; AKOS027420462; CF-0252; CS-1212; Nilotinib hydrochloride monohydrate CRS; Nilotinib monohydrochloride monohydrate?; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, monohydrochloride, monohydrate; AC-28467; DA-56185; SY235560; Nilotinib hydrochloride monohydrate [WHO-DD]; D06413; F862551; Nilotinib (monohydrochloride monohydrate) (Standard); Q27262451; 4-Methyl-N-[3-(4-methyl-1-imidazolyl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzamide Hydrochloride Hydrate; 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide hydrochloride monohydrate; 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide--hydrogen chloride--water (1/1/1); 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide monohydrochloride monohydrate; 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzamide;hydrate;hydrochloride; Chlorhydrate de nilotinib monohydraté; Nilotinib (chlorhydrate de) monohydraté; Nilotinib hidrocloruro monohidratoSinónimos